Suzanne R. Kalb
- Neurology top 1%
- Botulinum Toxin and Related Neurological Disorders 48
- Neurological disorders and treatments 36
- Endocrinology top 2%
- Diphtheria, Corynebacterium, and Tetanus 5
-
- Hereditary Neurological Disorders 20
- Genetic Neurodegenerative Diseases 6
- Molecular Medicine top 5%
- Biotechnology top 5%
- Transgenic Plants and Applications 6
-
- Streptococcal Infections and Treatments 12
-
- Toxin Mechanisms and Immunotoxins 6
Suzanne R. Kalb
69 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 110
- Neurology 1.2k
- Endocrinology 247
- Cellular and Molecular Neuroscience 667
- Molecular Medicine 112
- Biotechnology 158
Countries citing papers authored by Suzanne R. Kalb
This map shows the geographic impact of Suzanne R. Kalb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne R. Kalb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne R. Kalb more than expected).
Fields of papers citing papers by Suzanne R. Kalb
This network shows the impact of papers produced by Suzanne R. Kalb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne R. Kalb. The network helps show where Suzanne R. Kalb may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Suzanne R. Kalb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 8 | |
| 4 | 2021 | 13 | |
| 5 | 2020 | 8 | |
| 6 | 2019 | 5 | |
| 7 | 2017 | 15 | |
| 8 | 2017 | 13 | |
| 9 | 2015 | 35 | |
| 10 | 2015 | 23 | |
| 11 | 2015 | 30 | |
| 12 | 2015 | 5 | |
| 13 | 2013 | 7 | |
| 14 | 2012 | 15 | |
| 15 | 2011 | 35 | |
| 16 | 2011 | 21 | |
| 17 | 2005 | 37 | |
| 18 | 2003 | 52 | |
| 19 | 2003 | 31 | |
| 20 | 2003 | 100 |
About Suzanne R. Kalb
Suzanne R. Kalb is a scholar working on Neurology, Cellular and Molecular Neuroscience and Endocrinology, having authored 69 papers that have together received 2.3k indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (48 papers), Neurological disorders and treatments (36 papers), Hereditary Neurological Disorders (20 papers), Streptococcal Infections and Treatments (12 papers), Genetic Neurodegenerative Diseases (6 papers), Transgenic Plants and Applications (6 papers), Toxin Mechanisms and Immunotoxins (6 papers) and Diphtheria, Corynebacterium, and Tetanus (5 papers). The work is most often cited by research in Neurology (1.2k citations), Endocrinology (247 citations) and Cellular and Molecular Neuroscience (667 citations). Suzanne R. Kalb has collaborated with scholars based in United States, France and Argentina. Frequent co-authors include John R. Barr, Robert J. Cotter, Christian R.H. Raetz, Jakub Baudys, James L. Pirkle, Hércules Moura, Anne E. Boyer, Dongxia Wang, Lisa G. McWilliams and Susan E. Maslanka. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.